{"id":36970,"date":"2025-04-29T23:32:37","date_gmt":"2025-04-29T23:32:37","guid":{"rendered":"https:\/\/beyondtype1.org\/sequel-y-senseonics-unen-fuerzas-para-mejorar-el-manejo-de-la-diabetes\/"},"modified":"2025-04-29T23:37:18","modified_gmt":"2025-04-29T23:37:18","slug":"sequel-y-senseonics-manejo-de-la-diabetes","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/","title":{"rendered":"Sequel y Senseonics unen fuerzas para mejorar el manejo de la diabetes"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Sequel Med Tech, LLC, y Senseonics Holdings, Inc. han anunciado un acuerdo de desarrollo comercial para integrar tecnolog&iacute;as avanzadas para la diabetes. La alianza combina las tecnolog&iacute;as de Sequel. <\/span><a href=\"https:\/\/beyondtype1.org\/es\/twiist-integracion-freestyle-libre-3-plus\/\"><span style=\"font-weight: 400;\">Sistema de administraci&oacute;n autom&aacute;tica de insulina (AID) twiist<\/span><\/a> <span style=\"font-weight: 400;\">con<\/span> <a href=\"https:\/\/beyondtype1.org\/es\/fda-eversense-365\/\"><span style=\"font-weight: 400;\">Eversense 365 de Senseonics<\/span><\/a> <span style=\"font-weight: 400;\">, el &uacute;nico sistema de monitoreo continuo de glucosa (MCG) implantable con duraci&oacute;n de un a&ntilde;o.<\/span><\/p>\n<h3><b>Avances clave en la administraci&oacute;n autom&aacute;tica de insulina<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">El sistema twiist AID, impulsado por el algoritmo Tidepool Loop, ajusta autom&aacute;ticamente<\/span> la administraci&oacute;n <a href=\"https:\/\/beyondtype1.org\/es\/todo-sobre-la-insulina\/\"><span style=\"font-weight: 400;\">de insulina<\/span><\/a> <span style=\"font-weight: 400;\">en funci&oacute;n de las lecturas de glucosa en tiempo real.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El sistema est&aacute; aprobado por la FDA para personas de seis a&ntilde;os o m&aacute;s con diabetes tipo 1. <\/span><\/p>\n<h3><b>Opciones ampliadas para el manejo de la diabetes<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Esta colaboraci&oacute;n ampl&iacute;a las opciones de MCG para los usuarios del sistema twiist, quienes ahora podr&aacute;n elegir entre Eversense 365 de Senseonics y<\/span> <a href=\"https:\/\/beyondtype1.org\/es\/freestylelibre3-aprobacion-fda\/\"><span style=\"font-weight: 400;\">FreeStyle Libre 3 Plus de Abbott<\/span><\/a> <span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El objetivo es brindar mayor personalizaci&oacute;n, conveniencia y un mejor control de la glucosa para las personas con diabetes. <\/span><\/p>\n<h3><b>Cronograma de integraci&oacute;n y disponibilidad<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Eversense 365 recibi&oacute; la autorizaci&oacute;n de la FDA en 2024 como sistema MCG integrado (iCGM). <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Se espera que su compatibilidad con el sistemaTwiist est&eacute; disponible comercialmente en el tercer trimestre de 2025.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Para obtener m&aacute;s informaci&oacute;n, visita<\/span> <a href=\"http:\/\/www.sequelmedtech.com\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">www.sequelmedtech.com<\/span><\/a> <span style=\"font-weight: 400;\">y<\/span> <a href=\"http:\/\/www.eversensediabetes.com\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">www.eversensediabetes.com<\/span><\/a> <span style=\"font-weight: 400;\">.<\/span><\/p>\n<p>&nbsp;<\/p>\n\n","protected":false},"excerpt":{"rendered":"<p> El sistema twiist de Sequel ahora se integra con el MCG Eversense 365 de Senseonics, ofreciendo un MCG implantable durante un a\u00f1o para un cuidado flexible de la diabetes.<\/p>\n","protected":false},"author":11,"featured_media":36963,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-36970","resources","type-resources","status-publish","has-post-thumbnail","hentry","topics-tecnologia-y-equipamiento","diabetes-types-tipo-1","tags-mcg","tags-noticias","tags-tecnologia"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sequel y Senseonics unen fuerzas para mejorar el manejo de la diabetes | Beyond Type 1<\/title>\n<meta name=\"description\" content=\"El sistema de administraci\u00f3n autom\u00e1tica de insulina twiist de Sequel ahora se integra con el MCG Eversense 365 de Senseonics, ofreciendo un MCG implantable que dura un a\u00f1o para un cuidado flexible de la diabetes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sequel y Senseonics unen fuerzas para mejorar el manejo de la diabetes | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"El sistema de administraci\u00f3n autom\u00e1tica de insulina twiist de Sequel ahora se integra con el MCG Eversense 365 de Senseonics, ofreciendo un MCG implantable que dura un a\u00f1o para un cuidado flexible de la diabetes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-29T23:37:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/04\/BT1-SEQUEL-SENSEONICS-JOIN-FORCES-THUMBNAIL.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1380\" \/>\n\t<meta property=\"og:image:height\" content=\"776\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/\",\"url\":\"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/\",\"name\":\"Sequel y Senseonics unen fuerzas para mejorar el manejo de la diabetes | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/04\/BT1-SEQUEL-SENSEONICS-JOIN-FORCES-THUMBNAIL.jpg\",\"datePublished\":\"2025-04-29T23:32:37+00:00\",\"dateModified\":\"2025-04-29T23:37:18+00:00\",\"description\":\"El sistema de administraci\u00f3n autom\u00e1tica de insulina twiist de Sequel ahora se integra con el MCG Eversense 365 de Senseonics, ofreciendo un MCG implantable que dura un a\u00f1o para un cuidado flexible de la diabetes.\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/#primaryimage\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/04\/BT1-SEQUEL-SENSEONICS-JOIN-FORCES-THUMBNAIL.jpg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/04\/BT1-SEQUEL-SENSEONICS-JOIN-FORCES-THUMBNAIL.jpg\",\"width\":1380,\"height\":776,\"caption\":\"Sequel and Senseonics Join Forces to Enhance Diabetes Management\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtype1.org\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sequel y Senseonics unen fuerzas para mejorar el manejo de la diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtype1.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/beyondtype1\",\"https:\/\/x.com\/BeyondType1\",\"http:\/\/instagram.com\/BeyondType1\/\",\"https:\/\/www.youtube.com\/c\/BeyondType1\",\"https:\/\/www.tiktok.com\/@beyondtype1\",\"https:\/\/www.linkedin.com\/company\/beyond-type1\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sequel y Senseonics unen fuerzas para mejorar el manejo de la diabetes | Beyond Type 1","description":"El sistema de administraci\u00f3n autom\u00e1tica de insulina twiist de Sequel ahora se integra con el MCG Eversense 365 de Senseonics, ofreciendo un MCG implantable que dura un a\u00f1o para un cuidado flexible de la diabetes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/","og_locale":"es_ES","og_type":"article","og_title":"Sequel y Senseonics unen fuerzas para mejorar el manejo de la diabetes | Beyond Type 1","og_description":"El sistema de administraci\u00f3n autom\u00e1tica de insulina twiist de Sequel ahora se integra con el MCG Eversense 365 de Senseonics, ofreciendo un MCG implantable que dura un a\u00f1o para un cuidado flexible de la diabetes.","og_url":"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","article_modified_time":"2025-04-29T23:37:18+00:00","og_image":[{"width":1380,"height":776,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/04\/BT1-SEQUEL-SENSEONICS-JOIN-FORCES-THUMBNAIL.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/","url":"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/","name":"Sequel y Senseonics unen fuerzas para mejorar el manejo de la diabetes | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/04\/BT1-SEQUEL-SENSEONICS-JOIN-FORCES-THUMBNAIL.jpg","datePublished":"2025-04-29T23:32:37+00:00","dateModified":"2025-04-29T23:37:18+00:00","description":"El sistema de administraci\u00f3n autom\u00e1tica de insulina twiist de Sequel ahora se integra con el MCG Eversense 365 de Senseonics, ofreciendo un MCG implantable que dura un a\u00f1o para un cuidado flexible de la diabetes.","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/04\/BT1-SEQUEL-SENSEONICS-JOIN-FORCES-THUMBNAIL.jpg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/04\/BT1-SEQUEL-SENSEONICS-JOIN-FORCES-THUMBNAIL.jpg","width":1380,"height":776,"caption":"Sequel and Senseonics Join Forces to Enhance Diabetes Management"},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/sequel-y-senseonics-manejo-de-la-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"Sequel y Senseonics unen fuerzas para mejorar el manejo de la diabetes"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/36970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=36970"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/36970\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/36963"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=36970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}